Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)-Reference-Cited by-同舟云学术

Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)

Published:2017-01-15 Issue: Volume: Page:dkw557
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:J. Antimicrob. Chemother.

Author:

Di Giambenedetto Simona,Fabbiani Massimiliano,Quiros Roldan Eugenia,Latini Alessandra,D’Ettorre Gabriella,Antinori Andrea,Castagna Antonella,Orofino Giancarlo,Francisci Daniela,Chinello Pierangelo,Madeddu Giordano,Grima Pierfrancesco,Rusconi Stefano,Di Pietro Massimo,Mondi Annalisa,Ciccarelli Nicoletta,Borghetti Alberto,Focà Emanuele,Colafigli Manuela,De Luca Andrea,Cauda Roberto,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Reference26 articles.

1. Mortality in the Highly Active Antiretroviral Therapy Era

2. A Review of the Toxicity of HIV Medications

3. Switch to ritonavir-boosted atazanavir plus raltegravir in virologically suppressed patients with HIV-1 infection: a randomized pilot study;Van Lunzen;J Acquir Immune Defic Syndr,2016

4. Effectiveness of Protease Inhibitor Monotherapy versus Combination Antiretroviral Maintenance Therapy: A Meta-Analysis

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-Drug Regimen Containing Darunavir: Metabolic Evaluation of an Old Dual Therapy;AIDS Research and Human Retroviruses;2023-12-01

2. Two-drug antiretroviral regimens for HIV;BMJ;2023-09-01

3. Efficacy and safety of switching lamivudine-based dual therapies for the maintenance of virologic suppression in adults with HIV-1: a systematic review and network meta-analysis;2023-08-17

4. Two-drug regimens for HIV treatment;The Lancet HIV;2022-12

5. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12